Comparison of biochemical parameters of prevalent hemoglobinopathies with healthy individuals

Basit Öğe Kaydı
dc.contributor.authorYerlikaya, Emrah
dc.contributor.authorKarageçili, Hasan
dc.contributor.authorKaya, Mustafa Oğuzhan
dc.date.accessioned2024-12-24T19:18:26Z
dc.date.available2024-12-24T19:18:26Z
dc.date.issued2020
dc.departmentSiirt Üniversitesi
dc.description.abstractThalassemia is the most frequently seen monogenetic disorders around the world that is inherited as a recessive single-gene disease, resulting from mutations in ?-or?-globin gene clusters. In this study Beta Thalassemia Intermedia, Beta Thalassemia Minor, Sickle Cell Disease patients and the healthy control individuals both incidence and serum parameters were examined and analyzed retrospectively between 2015-2017 from Public Health information system. Beta Thalassemia Intermedia, BetaThalassemia Major, Beta Thalassemia Minor and Sickle Cell Disease patient groups incidences were evaluated on the basis of their HPLC analysis. Patients and controlgroups serum parameters levels were analyzed from their autoanalyzer results. These serum biochemical tests datas were controlled and taken from Siirt Public HealthCentre information system. In each year, there were recorded approximately 12 Beta Talassemia patients, 2 Beta Thallassemia Major patients, 340 Beta ThalassemiaMinor patients and 33 Sickle Cell Disease patients.Beta Thalassemia Intermedia patients serum parameters levels were compared with Beta Thalassemia Minor Patientsserum parameters and control group serum levels. There were seen statisticaly significant difference between Beta Thalassemia Intermedia patient’s serum ast, albumin,creatine, amylase, phosphor, iron, iron binding capacity, total protein, sodium, bilirubin direct, bilirubin total, LDH level and control serum parameters levels, p<0.05. Butthere were not seen statistically significant differences between Beta Thalassemia Minor patients serum levels and control serum levels. Studies like this should be donenationwide, in each city to determine the current state of abnormal hemoglobinopathies in Turkey. Thus, a broader, comprehensive national screening program is needed.
dc.identifier.doi10.5455/medscience.2019.04.049
dc.identifier.endpage713
dc.identifier.issn2147-0634
dc.identifier.issue3
dc.identifier.startpage708
dc.identifier.trdizinid367495
dc.identifier.urihttps://doi.org/10.5455/medscience.2019.04.049
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/367495
dc.identifier.urihttps://hdl.handle.net/20.500.12604/5103
dc.identifier.volume9
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.relation.ispartofMedicine Science
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241222
dc.subjectGenel ve Dahili Tıp,Hematoloji
dc.titleComparison of biochemical parameters of prevalent hemoglobinopathies with healthy individuals
dc.typeArticle

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu